-+ 0.00%
-+ 0.00%
-+ 0.00%

BTIG Reiterates Buy on Perspective Therapeutics, Maintains $14 Price Target

Benzinga·05/05/2026 11:42:23
Listen to the news
BTIG analyst Jeet Mukherjee reiterates Perspective Therapeutics (AMEX:CATX) with a Buy and maintains $14 price target.